FDA — authorised 2 February 1977
- Application: ANDA085017
- Marketing authorisation holder: KEY PHARMS
- Local brand name: GENAPAX
- Indication: TAMPON — VAGINAL
- Status: approved
🇺🇸 Methylrosaniline Chloride in United States
FDA authorised Methylrosaniline Chloride on 2 February 1977
Marketing authorisations
FDA
- Status: approved
FDA
- Application: ANDA083513
- Marketing authorisation holder: SAVAGE LABS
- Local brand name: GVS
- Indication: SUPPOSITORY — VAGINAL
- Status: approved
Methylrosaniline Chloride in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Methylrosaniline Chloride approved in United States?
Yes. FDA authorised it on 2 February 1977; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Methylrosaniline Chloride in United States?
KEY PHARMS holds the US marketing authorisation.